Cite
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
MLA
Morizane, Chigusa, et al. “A Phase II Study of S-1 in Gemcitabine-Refractory Metastatic Pancreatic Cancer.” Cancer Chemotherapy & Pharmacology, vol. 63, no. 2, Jan. 2009, pp. 313–19. EBSCOhost, https://doi.org/10.1007/s00280-008-0741-7.
APA
Morizane, C., Okusaka, T., Furuse, J., Ishii, H., Ueno, H., Ikeda, M., Nakachi, K., Najima, M., Ogura, T., & Suzuki, E. (2009). A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer. Cancer Chemotherapy & Pharmacology, 63(2), 313–319. https://doi.org/10.1007/s00280-008-0741-7
Chicago
Morizane, Chigusa, Takuji Okusaka, Junji Furuse, Hiroshi Ishii, Hideki Ueno, Masafumi Ikeda, Kohei Nakachi, Mina Najima, Takashi Ogura, and Eiichiro Suzuki. 2009. “A Phase II Study of S-1 in Gemcitabine-Refractory Metastatic Pancreatic Cancer.” Cancer Chemotherapy & Pharmacology 63 (2): 313–19. doi:10.1007/s00280-008-0741-7.